Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Breast Cancer

Free Subscription Articles published in Cancer Cell Retrieve available abstracts of 36 articles: HTML format

Single Articles

June 2026
1. CRUZ-REYES N, Radisky DC
   When tissue tension creates a mutagenic niche.
   Cancer Cell. 2026;44:1111-1112.
   PubMed     Abstract available
   
   
   
2. HAYWARD MK, Northey JJ, Opazo-Mellado V, Stashko C, et al
   Tissue tension fosters macrophage-driven lipid peroxidation-induced DNA damage.
   Cancer Cell. 2026;44:1255-1269.
   PubMed     Abstract available
   
   
   
3. YUAN X, Yu D
   Rethinking immune states in brain metastasis.
   Cancer Cell. 2026;44:1116-1118.
   PubMed     Abstract available
   
   
   
4. BUI TM, Jimenez ER, Li Z, Foidart P, et al
   Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression.
   Cancer Cell. 2026;44:1179-1200.
   PubMed     Abstract available
   
   
   April 2026
5. JASSOWICZ L, Feng F, Warta R, Heinicke F, et al
   Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes.
   Cancer Cell. 2026 Apr 27:S1535-6108(26)00170-4. doi: 10.1016/j.ccell.2026.
   PubMed     Abstract available
   
   
   February 2026
6. GOMEZ MARTI JL, Michaels E, Nasrazadani A, Wander SA, et al
   Enhancing therapeutic outcomes with artificial intelligence for HR-positive, HER2-negative metastatic breast cancer.
   Cancer Cell. 2026;44:254-256.
   PubMed     Abstract available
   
   
   December 2025
7. MIGLIOZZI S, Adabbo B, Garofano L, Wu F, et al
   Restraint of cancer cell plasticity by spatial homotypic clustering.
   Cancer Cell. 2025;43:2206-2223.
   PubMed     Abstract available
   
   
   
8. FAN L, Zhang WJ, Li HP, Zeng XH, et al
   Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.
   Cancer Cell. 2025 Dec 4:S1535-6108(25)00496-9. doi: 10.1016/j.ccell.2025.
   PubMed     Abstract available
   
   
   September 2025
9. ZHOU YF, Ma D, Shao ZM
   TNBC's compass: Navigating prognosis with a cellular map.
   Cancer Cell. 2025;43:1598-1600.
   PubMed     Abstract available
   
   
   
10. HE D, Wu Q, Tian P, Liu Y, et al
    Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps.
    Cancer Cell. 2025;43:1622-1636.
    PubMed     Abstract available
    
    
    
11. JASSIM A, Nimmervoll BV, Terranova S, Nathan E, et al
    Gene context drift identifies drug targets to mitigate cancer treatment resistance.
    Cancer Cell. 2025;43:1608-1621.
    PubMed     Abstract available
    
    
    July 2025
12. MEYER L, Jackson HW, Eling N, Zhao S, et al
    A stratification system for breast cancer based on basoluminal tumor cells and spatial tumor architecture.
    Cancer Cell. 2025 Jul 16:S1535-6108(25)00269-7. doi: 10.1016/j.ccell.2025.
    PubMed     Abstract available
    
    
    
13. GARNER H, Martinovic M, Liu NQ, Bakker NAM, et al
    Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread.
    Cancer Cell. 2025;43:1279-1295.
    PubMed     Abstract available
    
    
    
14. ROZALEN C, Sangrador I, Avalle S, Blasco-Benito S, et al
    TIM3(+) breast cancer cells license immune evasion during micrometastasis outbreak.
    Cancer Cell. 2025 Jul 7:S1535-6108(25)00265-X. doi: 10.1016/j.ccell.2025.
    PubMed     Abstract available
    
    
    June 2025
15. VOGEL I, Bapat SP
    TAMing immunity through an unexpected source.
    Cancer Cell. 2025;43:1002-1004.
    PubMed     Abstract available
    
    
    
16. ZHU Y, Zhou Z, Du X, Lin X, et al
    Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion.
    Cancer Cell. 2025;43:1045-1060.
    PubMed     Abstract available
    
    
    April 2025
17. MA D, Dai LJ, Wu XR, Liu CL, et al
    Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer.
    Cancer Cell. 2025 Apr 4:S1535-6108(25)00118-7. doi: 10.1016/j.ccell.2025.
    PubMed     Abstract available
    
    
    March 2025
18. PALMER CL, Boras B, Pascual B, Li N, et al
    CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety.
    Cancer Cell. 2025;43:464-481.
    PubMed     Abstract available
    
    
    
19. LIU T, Ellisen LW
    Exploring the "chemo" in chemoimmunotherapy for triple-negative breast cancer.
    Cancer Cell. 2025;43:332-334.
    PubMed     Abstract available
    
    
    February 2025
20. DENKERT C, Rachakonda S, Karn T, Weber K, et al
    Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping.
    Cancer Cell. 2025;43:232-247.
    PubMed     Abstract available
    
    
    
21. BIANCHINI G, Viale G, Dugo M
    From intrinsic to adaptive clusters in breast cancer.
    Cancer Cell. 2025;43:171-173.
    PubMed     Abstract available
    
    
    January 2025
22. ZHANG Y, Chen H, Mo H, Zhao N, et al
    Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer.
    Cancer Cell. 2025 Jan 30:S1535-6108(25)00025-X. doi: 10.1016/j.ccell.2025.
    PubMed     Abstract available
    
    
    
23. YANG Z, Liu X, Zhu J, Chai Y, et al
    Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1.
    Cancer Cell. 2025;43:86-102.
    PubMed     Abstract available
    
    
    December 2024
24. HANGGI K, Li J, Gangadharan A, Liu X, et al
    Interleukin-1alpha release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity.
    Cancer Cell. 2024;42:2015-2031.
    PubMed     Abstract available
    
    
    November 2024
25. KUDO R, Safonov A, Jones C, Moiso E, et al
    Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.
    Cancer Cell. 2024;42:1983.
    PubMed    
    
    
    
26. YAN P, Jimenez ER, Li Z, Bui T, et al
    Midkine as a driver of age-related changes and increase in mammary tumorigenesis.
    Cancer Cell. 2024;42:1936-1954.
    PubMed     Abstract available
    
    
    October 2024
27. KUDO R, Safonov A, Jones C, Moiso E, et al
    Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.
    Cancer Cell. 2024 Oct 4:S1535-6108(24)00357-X. doi: 10.1016/j.ccell.2024.
    PubMed     Abstract available
    
    
    September 2024
28. VISVADER JE
    Midkine links aging with breast cancer-A new predictor of cancer risk.
    Cancer Cell. 2024 Sep 30:S1535-6108(24)00351-9. doi: 10.1016/j.ccell.2024.
    PubMed     Abstract available
    
    
    
29. GAN S, Macalinao DG, Shahoei SH, Tian L, et al
    Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain.
    Cancer Cell. 2024 Sep 12:S1535-6108(24)00314-3. doi: 10.1016/j.ccell.2024.
    PubMed     Abstract available
    
    
    
30. BOON M, Akkari L
    Architecture sets the path: Breast cancer subtypes differently shape the early brain metastatic niche.
    Cancer Cell. 2024 Sep 12:S1535-6108(24)00320-9. doi: 10.1016/j.ccell.2024.
    PubMed     Abstract available
    
    
    June 2024
31. ELKHOLI IE, Rose AAN, Aguirre-Ghiso JA, Cote JF, et al
    How can we integrate the biology of breast cancer cell dormancy into clinical practice?
    Cancer Cell. 2024 Jun 12:S1535-6108(24)00191-0. doi: 10.1016/j.ccell.2024.
    PubMed     Abstract available
    
    
    
32. LI Y, Huang M, Wang M, Wang Y, et al
    Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite.
    Cancer Cell. 2024;42:985-1002.
    PubMed     Abstract available
    
    
    May 2024
33. MCGINNIS CS, Miao Z, Superville D, Yao W, et al
    The temporal progression of lung immune remodeling during breast cancer metastasis.
    Cancer Cell. 2024 May 24:S1535-6108(24)00167-3. doi: 10.1016/j.ccell.2024.
    PubMed     Abstract available
    
    
    
34. LAYER N, Bunse L, Venkataramani V
    Neural deception: Breast cancer co-opts neuronal mechanisms to evade the immune system.
    Cancer Cell. 2024 May 17:S1535-6108(24)00170-3. doi: 10.1016/j.ccell.2024.
    PubMed     Abstract available
    
    
    April 2024
35. LIN CJ, Jin X, Ma D, Chen C, et al
    Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.
    Cancer Cell. 2024;42:701-719.
    PubMed     Abstract available
    
    
    March 2024
36. BEJARANO L, Kauzlaric A, Lamprou E, Lourenco J, et al
    Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms.
    Cancer Cell. 2024;42:378-395.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum